Viemed Healthcare Inc

Viemed Healthcare insider selling: Michael Moore’s March sales barely impact control, but raise caution signals amid solid fundamentals and a niche sleep‑apnea market. Dive into valuation, risk factors and investor takeaways.

Insider trades show Viemed’s CMO buying shares while liquidating phantom units, signaling confidence and potential for a future round or M&A.